VIVIAN MENCHACA: Open Payments
NPI 1427010073 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 22 payments from 7 companies in 2025. Trend: 2023 $674 · 2024 $521 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $247 |
| PFIZER INC. | 5 | $118 |
| Exact Sciences Corporation | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Seqirus USA Inc | 1 | $29 |
| Amgen Inc. | 1 | $19 |
| SI-BONE, INC. | 1 | $19 |
Products named: AIRSUPRA, TRUMENBA, The Cologuard Plus Collection Kit, Fluad, OTEZLA, BEXSERO, SHINGRIX, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
